Orbimed Advisors, Director: Terns Pharmaceuticals TERN Sell · Filed 24/07/17

Trade details

Type: Insider sale
Amount: $394,330
Shares · price: 39,433 sh · $10.00 a share
Held after: 4,843,421 sh
Stock: Terns Pharmaceuticals TERN
Person: Orbimed AdvisorsDirector
Trade date: 24/07/15
Filed: 24/07/17
Days to filing: 2 days

Sold 0.8% of holdings

Share of holding sold: 0.8%

Terns Pharmaceuticals trades, last 26 weeks

What else happened in Terns Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/06/15~24/08/14

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21
Orbimed Advisors10% Owner
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$35.7M
787,024 sh
$35.7M
Filed 06/24
Traded 06/22
Orbimed Advisors10% Owner
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$2.1M
46,776 sh
$2.1M
Filed 06/24
Traded 06/22
Orbimed Advisors10% Owner
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$1.1M
24,846 sh
$1.1M
Filed 06/24
Traded 06/22